Quality-Adjusted Life Years
"Quality-Adjusted Life Years" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. (BIOETHICS Thesaurus, 1994)
Descriptor ID |
D019057
|
MeSH Number(s) |
E05.318.740.100.500.700 N01.224.935.530.700
|
Concept/Terms |
Quality-Adjusted Life Years- Quality-Adjusted Life Years
- Life Year, Quality-Adjusted
- Life Years, Quality-Adjusted
- Quality-Adjusted Life Year
- Year, Quality-Adjusted Life
- Years, Quality-Adjusted Life
- Quality Adjusted Life Years
- QALY
Adjusted Life Years- Adjusted Life Years
- Adjusted Life Year
- Life Year, Adjusted
- Life Years, Adjusted
- Year, Adjusted Life
- Years, Adjusted Life
|
Below are MeSH descriptors whose meaning is more general than "Quality-Adjusted Life Years".
Below are MeSH descriptors whose meaning is more specific than "Quality-Adjusted Life Years".
This graph shows the total number of publications written about "Quality-Adjusted Life Years" by people in this website by year, and whether "Quality-Adjusted Life Years" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 1 | 2 |
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
1999 | 1 | 1 | 2 |
2002 | 0 | 1 | 1 |
2003 | 1 | 3 | 4 |
2004 | 0 | 2 | 2 |
2005 | 2 | 2 | 4 |
2006 | 0 | 5 | 5 |
2007 | 0 | 4 | 4 |
2008 | 2 | 3 | 5 |
2009 | 1 | 3 | 4 |
2010 | 0 | 4 | 4 |
2011 | 1 | 3 | 4 |
2012 | 4 | 6 | 10 |
2013 | 2 | 7 | 9 |
2014 | 2 | 7 | 9 |
2015 | 2 | 12 | 14 |
2016 | 0 | 5 | 5 |
2017 | 3 | 8 | 11 |
2018 | 4 | 7 | 11 |
2019 | 0 | 6 | 6 |
2020 | 2 | 9 | 11 |
2021 | 1 | 8 | 9 |
2022 | 0 | 3 | 3 |
2023 | 0 | 3 | 3 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Quality-Adjusted Life Years" by people in Profiles.
-
Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. Pharmacoeconomics. 2024 Apr; 42(4):409-418.
-
Cardiovascular disease burden in the Middle East and North Africa region. Curr Probl Cardiol. 2024 Mar; 49(3):102341.
-
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 2023 08; 41(8):857-867.
-
Cost-utility analysis of a multispecialty interprofessional team dementia care model in Ontario, Canada. BMJ Open. 2023 04 19; 13(4):e064882.
-
Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods. Genet Med. 2022 10; 24(10):2014-2027.
-
A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer Oligometastases. Int J Radiat Oncol Biol Phys. 2022 12 01; 114(5):977-988.
-
The Optimal Length of Stay after Microvascular Breast Reconstruction: A Cost-Utility Analysis. Plast Reconstr Surg. 2022 08 01; 150(2):279e-289e.
-
Are Medical Devices Cost-Effective? Appl Health Econ Health Policy. 2022 03; 20(2):235-241.
-
Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications. Value Health. 2022 01; 25(1):59-68.
-
Mogamulizumab for Previously Treated Mycosis Fungoides and S?zary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 2022 05; 40(5):509-518.